Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
90,124,434
-
Share change
-
+674,810
-
Total reported value
-
$10,754,797,482
-
Put/Call ratio
-
28%
-
Price per share
-
$119.44
-
Number of holders
-
525
-
Value change
-
+$104,201,709
-
Number of buys
-
278
-
Number of sells
-
206
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2022
As of 31 Dec 2022,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
525 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,124,434 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bellevue Group AG, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, MORGAN STANLEY, Avidity Partners Management LP, Bank of New York Mellon Corp, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
525
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.